| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0168-8278(99)80098-1 |
| P698 | PubMed publication ID | 10190722 |
| P2093 | author name string | B Balkau | |
| O Chazouillères | |||
| R Poupon | |||
| R E Poupon | |||
| P2860 | cites work | A multicenter, controlled trial of ursodiol for the treatment of primary biliary cirrhosis. UDCA-PBC Study Group | Q28243457 |
| The pruritus of cholestasis and the opioid system | Q34239166 | ||
| Histopathological features in mixed types of chronic aggressive hepatitis and primary biliary cirrhosis. Correlations of liver histology with mitochondrial antibodies of different specificity | Q39809553 | ||
| The control of pain in peripheral tissue by opioids. | Q40531445 | ||
| A 33-year-old woman with an autoimmune syndrome | Q43550973 | ||
| The problem of histologic evaluation of primary biliary cirrhosis | Q66841743 | ||
| Chronic active hepatitis with histological features of primary biliary cirrhosis | Q68822637 | ||
| Sequential and diagnostic features in primary biliary cirrhosis based on serial histologic study in 209 patients | Q70109771 | ||
| Primary biliary cirrhosis | Q71742524 | ||
| Primary biliary cirrhosis-autoimmune hepatitis overlap syndrome. Corticoresistance and effective treatment by cyclosporine A | Q72188593 | ||
| Autoimmune cholangiopathy: the result of consecutive primary biliary cirrhosis and autoimmune hepatitis? | Q72800622 | ||
| Sustained biochemical and histologic remission of primary biliary cirrhosis in response to medical treatment | Q73316077 | ||
| Primary biliary cirrhosis-autoimmune hepatitis overlap syndrome: clinical features and response to therapy | Q77058192 | ||
| P433 | issue | 3 | |
| P921 | main subject | primary biliary cholangitis | Q1072420 |
| P304 | page(s) | 408-412 | |
| P577 | publication date | 1999-03-01 | |
| P1433 | published in | Journal of Hepatology | Q15724402 |
| P1476 | title | Clinical and biochemical expression of the histopathological lesions of primary biliary cirrhosis. UDCA-PBC Group | |
| P478 | volume | 30 |
| Q64077115 | A Practical Review of Primary Biliary Cholangitis for the Gastroenterologist |
| Q73419940 | Aberrant expression of cytokeratin 7 as a histological marker of progression in primary biliary cirrhosis |
| Q34594429 | Anti-gp210 and anti-centromere antibodies are different risk factors for the progression of primary biliary cirrhosis |
| Q90443379 | Apoptosis induced by ursodeoxycholic acid in human melanoma cells through the mitochondrial pathway |
| Q34746158 | Autoimmune hepatitis and overlap syndromes |
| Q35573912 | Autoimmune overlapping syndromes |
| Q36193470 | Case-control study on prednisolone combined with ursodeoxycholic acid and azathioprine in pure primary biliary cirrhosis with high levels of immunoglobulin G and transaminases: efficacy and safety analysis |
| Q91795125 | Clinical Updates in Primary Biliary Cholangitis: Trends, Epidemiology, Diagnostics, and New Therapeutic Approaches |
| Q24247122 | Colchicine for primary biliary cirrhosis |
| Q44487597 | Combined analysis of the effect of treatment with ursodeoxycholic acid on histologic progression in primary biliary cirrhosis |
| Q27333658 | Inhibition of the Unfolded Protein Response Mechanism Prevents Cardiac Fibrosis |
| Q38738566 | Pharmacological interventions for primary biliary cholangitis: an attempted network meta-analysis. |
| Q89639221 | Preventative care in cholestatic liver disease: Pearls for the specialist and subspecialist |
| Q90707736 | Primary Biliary Cholangitis: 2018 Practice Guidance from the American Association for the Study of Liver Diseases |
| Q56428273 | Primary biliary cirrhosis |
| Q26853649 | Primary biliary cirrhosis: Pathophysiology, clinical presentation and therapy |
| Q35573894 | Primary biliary cirrhosis—presentation and diagnosis |
| Q35573916 | Pruritus and fatigue in primary biliary cirrhosis |
| Q35628089 | Pruritus in chronic liver disease: mechanisms and treatment |
| Q44797516 | Studying pruritus in the 21st century |
| Q52624982 | The British Society of Gastroenterology/UK-PBC primary biliary cholangitis treatment and management guidelines. |
| Q35833175 | The diagnosis and treatment of primary biliary cirrhosis |
| Q24202184 | Ursodeoxycholic acid for primary biliary cirrhosis |
| Q33866782 | Ursodeoxycholic acid treatment of vanishing bile duct syndromes |
Search more.